These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7804666)
1. Tiapride in the prevention of relapse in recently detoxified alcoholics. Shaw GK; Waller S; Majumdar SK; Alberts JL; Latham CJ; Dunn G Br J Psychiatry; 1994 Oct; 165(4):515-23. PubMed ID: 7804666 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients. Bender S; Scherbaum N; Soyka M; Rüther E; Mann K; Gastpar M Int J Neuropsychopharmacol; 2007 Oct; 10(5):653-60. PubMed ID: 17076934 [TBL] [Abstract][Full Text] [Related]
3. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Shaw GK; Majumdar SK; Waller S; MacGarvie J; Dunn G Br J Psychiatry; 1987 Feb; 150():164-8. PubMed ID: 3307976 [TBL] [Abstract][Full Text] [Related]
4. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487 [TBL] [Abstract][Full Text] [Related]
5. Alcoholism: a long-term follow-up study of participants in an alcohol treatment programme. Shaw GK; Waller S; Latham CJ; Dunn G; Thomson AD Alcohol Alcohol; 1997; 32(4):527-35. PubMed ID: 9269861 [TBL] [Abstract][Full Text] [Related]
6. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Peters DH; Faulds D Drugs; 1994 Jun; 47(6):1010-32. PubMed ID: 7521826 [TBL] [Abstract][Full Text] [Related]
7. Clinical management of agitation in the elderly with tiapride. Robert PH; Allain H Eur Psychiatry; 2001 Jan; 16 Suppl 1():42s-47s. PubMed ID: 11520478 [TBL] [Abstract][Full Text] [Related]
8. Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea. Deroover J; Baro F; Bourguignon RP; Smets P Curr Med Res Opin; 1984; 9(5):329-38. PubMed ID: 6241563 [TBL] [Abstract][Full Text] [Related]
9. [Carbamazepine intoxication. Complication of alcohol detoxification with combined carbamazepine and tiapride]. Diehl A; Grosshans M; Herre H; Croissant B; Mann K Nervenarzt; 2007 Jan; 78(1):85-9. PubMed ID: 17186186 [TBL] [Abstract][Full Text] [Related]
10. Alcoholism: a follow-up study of participants in an alcohol treatment programme. Shaw GK; Waller S; McDougall S; MacGarvie J; Dunn G Br J Psychiatry; 1990 Aug; 157():190-6. PubMed ID: 2224369 [TBL] [Abstract][Full Text] [Related]
11. Effect of naltrexone on alcohol "high" in alcoholics. Volpicelli JR; Watson NT; King AC; Sherman CE; O'Brien CP Am J Psychiatry; 1995 Apr; 152(4):613-5. PubMed ID: 7694913 [TBL] [Abstract][Full Text] [Related]
12. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735 [TBL] [Abstract][Full Text] [Related]
14. The detoxification experience of alcoholic in-patients and predictors of outcome. Shaw GK; Waller S; Latham CJ; Dunn G; Thomson AD Alcohol Alcohol; 1998; 33(3):291-303. PubMed ID: 9632055 [TBL] [Abstract][Full Text] [Related]
15. Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Lucht M; Kuehn KU; Armbruster J; Abraham G; Gaensicke M; Barnow S; Tretzel H; Freyberger HJ Alcohol Alcohol; 2003; 38(2):168-75. PubMed ID: 12634266 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217 [TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Kranzler HR; Burleson JA; Korner P; Del Boca FK; Bohn MJ; Brown J; Liebowitz N Am J Psychiatry; 1995 Mar; 152(3):391-7. PubMed ID: 7864265 [TBL] [Abstract][Full Text] [Related]
18. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401 [TBL] [Abstract][Full Text] [Related]
19. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations. Greil W; Auberger S; Haag H; Rüther E Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426 [TBL] [Abstract][Full Text] [Related]
20. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]